FDA COVID-19 Guidance Roundup for Drug and Biologics

From the beginning of the coronavirus (COVID-19) pandemic, FDA actively provided guidance to members of the drug and biologic industries, including sponsors, investigators, pharmacies, and compounders....<BR />By: <a href="https://www.jdsupra.com/profile/morgan-lewis/">Morgan Lewis</a>

Array